Immunome Inc. Quarterly Operating Margin in % from Q4 2023 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Immunome Inc. quarterly/annual Operating Margin history and growth rate from Q4 2023 to Q3 2024.
  • Immunome Inc. Operating Margin for the quarter ending September 30, 2024 was -3.13K %.
Operating Margin, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -3.13K Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.52K Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.87K Jan 1, 2024 Mar 31, 2024
Q4 2023 -781 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.